Literature DB >> 24097849

Nutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings.

Rebecca Hurst Davis1, Barbara J Godshall2, Erin Seffrood3, Mary Marcus3, Bernard A LaSalle4, Brenda Wong5, Mary K Schroth3, Kathryn J Swoboda6.   

Abstract

Proactive nutritional management for children with spinal muscular atrophy type I can provide insight into improved spinal muscular atrophy care. This observational study consisted of a nutritional and medical history survey of children with spinal muscular atrophy type I collected in 2009-2011. Forty-four caregiver survey responses were evaluated using descriptive statistics. Average age of spinal muscular atrophy type I subjects was 5 years (5 mo-16 y). The subject cohort was composed of 22 males, 21 females, and 1 unreported. Nutrition support via feeding tube was utilized by 43 of 44 subjects. A majority of respondents reported using elemental or semi-elemental formula for subjects' essential caloric intake (34 of 44). Formula intolerance issues were reported by many caregivers (27 of 44). Half of caregivers implemented dietary changes on their own or with guidance from other families; 15 caregivers consulted a registered dietitian. Survey responses and comments indicate need for evidence-based nutritional guidelines for spinal muscular atrophy.
© The Author(s) 2013.

Entities:  

Keywords:  SMA nutrition; elemental diet; spinal muscular atrophy type I

Mesh:

Substances:

Year:  2013        PMID: 24097849      PMCID: PMC4334580          DOI: 10.1177/0883073813503988

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  26 in total

1.  Orocaecal transit time in Duchenne muscular dystrophy.

Authors:  S H Korman; B Bar-Oz; E Granot; S Meyer
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

2.  Segmental colonic transit time in Duchenne muscular dystrophy.

Authors:  F Gottrand; I Guillonneau; A Carpentier
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

3.  Classification of spinal muscular atrophies.

Authors:  J Pearn
Journal:  Lancet       Date:  1980-04-26       Impact factor: 79.321

4.  Abnormal fatty acid metabolism in childhood spinal muscular atrophy.

Authors:  T O Crawford; J T Sladky; O Hurko; A Besner-Johnston; R I Kelley
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

5.  Gastrostomy placement in paediatric patients with neuromuscular disorders: indications and outcome.

Authors:  Gian Paolo Ramelli; Annie Aloysius; Caroline King; Trak Davis; Francesco Muntoni
Journal:  Dev Med Child Neurol       Date:  2007-05       Impact factor: 5.449

6.  Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone health.

Authors:  Jennifer Aton; Rebecca Hurst Davis; Kristine C Jordan; Charles B Scott; Kathryn J Swoboda
Journal:  J Child Neurol       Date:  2013-01-17       Impact factor: 1.987

7.  Severe depletion of mitochondrial DNA in spinal muscular atrophy.

Authors:  Alexandra Berger; Johannes A Mayr; David Meierhofer; Ulrike Fötschl; Reginald Bittner; Herbert Budka; Claude Grethen; Michael Huemer; Barbara Kofler; Wolfgang Sperl
Journal:  Acta Neuropathol       Date:  2002-11-14       Impact factor: 17.088

Review 8.  Nutrition and swallowing in pediatric neuromuscular patients.

Authors:  A H Tilton; M D Miller; V Khoshoo
Journal:  Semin Pediatr Neurol       Date:  1998-06       Impact factor: 1.636

9.  Gastric hypomotility in Duchenne's muscular dystrophy.

Authors:  R J Barohn; E J Levine; J O Olson; J R Mendell
Journal:  N Engl J Med       Date:  1988-07-07       Impact factor: 91.245

10.  Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?

Authors:  I Tein; A E Sloane; E J Donner; D C Lehotay; D S Millington; R I Kelley
Journal:  Pediatr Neurol       Date:  1995-01       Impact factor: 3.372

View more
  13 in total

1.  Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden.

Authors:  Santiago Zuluaga-Sanchez; Megan Teynor; Christopher Knight; Robin Thompson; Thomas Lundqvist; Mats Ekelund; Annabelle Forsmark; Adrian D Vickers; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2019-06       Impact factor: 4.981

Review 2.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

3.  SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice.

Authors:  Sara E Gombash; Christopher J Cowley; Julie A Fitzgerald; Chitra C Iyer; David Fried; Vicki L McGovern; Kent C Williams; Arthur H M Burghes; Fedias L Christofi; Brian D Gulbransen; Kevin D Foust
Journal:  Hum Mol Genet       Date:  2015-04-09       Impact factor: 6.150

4.  Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module.

Authors:  Beatrice Berti; Lavinia Fanelli; Roberto de Sanctis; Roberta Onesimo; Concetta Palermo; Daniela Leone; Sara Carnicella; Giulia Norcia; Nicola Forcina; Giorgia Coratti; Valentina Giorgio; Antonella Cerchiari; Simona Lucibello; Richard Finkel; Marika Pane; Eugenio Mercuri
Journal:  J Neuromuscul Dis       Date:  2021

5.  Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment.

Authors:  Palittiya Sintusek; Francesco Catapano; Napat Angkathunkayul; Elena Marrosu; Simon H Parson; Jennifer E Morgan; Francesco Muntoni; Haiyan Zhou
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

6.  Feeding and Swallowing Disorders in Pediatric Neuromuscular Diseases: An Overview.

Authors:  Lenie van den Engel-Hoek; Imelda J M de Groot; Bert J M de Swart; Corrie E Erasmus
Journal:  J Neuromuscul Dis       Date:  2015-11-20

Review 7.  Emerging therapies and challenges in spinal muscular atrophy.

Authors:  Michelle A Farrar; Susanna B Park; Steve Vucic; Kate A Carey; Bradley J Turner; Thomas H Gillingwater; Kathryn J Swoboda; Matthew C Kiernan
Journal:  Ann Neurol       Date:  2017-02-17       Impact factor: 10.422

Review 8.  Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy.

Authors:  Yang-Jean Li; Tai-Heng Chen; Yan-Zhang Wu; Yung-Hao Tseng
Journal:  Nutrients       Date:  2020-12-16       Impact factor: 5.717

Review 9.  Metabolic Dysfunction in Spinal Muscular Atrophy.

Authors:  Marc-Olivier Deguise; Lucia Chehade; Rashmi Kothary
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future.

Authors:  Katlyn Elizabeth McGrattan; Robert J Graham; Christine J DiDonato; Basil T Darras
Journal:  Am J Speech Lang Pathol       Date:  2021-04-06       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.